Insights
Market commentary and guides
Global Macro
Today’s NY close will mark both the end of September and the end of the third quarter of 2016. Often times, these month-end, quarter-end…
Resmed – Buying Opportunity
Out of the three healthcare buy recommendations, (CSL, SHL and RMD), made in the blog post back on 13th of September, CSL has increased 10% and SHL 10%+, however, RMD…
Oil Search – Price Bounces Following OPEC Agreement
Oil Search (OSH.ASX) remains an attractive recovery story over the next few months with a potential price target back above $7.25. This target is seen…
Medibank – Is Value Emerging?
Medibank (MPL.ASX) is now trading at a price level that warrants attention. The stock is forecast to pay a fully franked dividend in FY17…
ASX Mid-Week – Video Update
I’ve decided this week to replace the usual multiple individual posts with a quick summary video. I think this does a better job of…
Global Macro
With global financial markets firmly focused on central bank meetings in the US and Japan last week, it was easy to overlook the bad news delivered…
Global Macro
While there was never a consensus that the FED was going to lift the overnight target rate going into last week’s FOMC meeting, there were…
Global Macro
The BoJ also announced that they would maintain its JPY 6 trillion a year purchases of equity exchange traded funds (ETFs), but widened the distribution…
XJO Index Watch – Key Levels you Should be Tracking
Following last night’s decision in the US to leave rates unchanged, yield stocks will begin their recovery as we forecasted. See our list of…
Navitas – Get Ready to Take Profit
Navitas (NVT.ASX) was recommended as a buy on the 15th August with an entry level at $5.00. The stock has rallied 5% plus, in a…